physostigmine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (95.65) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brundin, P; Chung, H; Colgan, L; Englund, E; Faull, RL; Li, JY; Liu, YJ; Maat-Schieman, ML; Roos, RA; Rundquist, S; Smith, R | 1 |
| Edge, PC; Grell, GA; Melville, GN; Wray, SR | 1 |
| Spar, JE | 1 |
| Nutt, JG | 1 |
| Barbeau, A | 1 |
| Barchas, JD; Berger, PA; Davis, KL; Hollister, LE | 2 |
| Kuran, W | 1 |
| Berger, PA; Davis, KL; Hollister, LE; Simonton, SC | 1 |
| Bralower, M; Tarsy, D | 1 |
| Casey, DE | 1 |
| Berger, PA; Davis, KL | 1 |
| Growdon, JH; Wurtman, RJ | 1 |
| Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F | 1 |
| Berger, PA; Davis, KL; Hollister, LE; Vento, AL | 1 |
| Enna, SJ | 1 |
| Hoehn, M; Lewis, J; Sears, E; Walker, JE | 1 |
| Klawans, HL; Rubovits, R | 1 |
| Fann, WE; Gerber, CJ; McKenzie, GM | 1 |
| Constantinidis, J | 1 |
| Aquilonius, SM; Sjöström, R | 2 |
| Leopold, N; Sax, DS; Tarsy, D | 1 |
4 review(s) available for physostigmine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats | 1981 |
Progress in understanding Huntington's chorea.
Topics: Acetylcholine; Acetylcholinesterase; Basal Ganglia; Blood-Brain Barrier; Brain; Catecholamines; Caudate Nucleus; Dopamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Homovanillic Acid; Humans; Huntington Disease; Hypothalamus; Parasympatholytics; Physostigmine; Receptors, Adrenergic; Receptors, Cholinergic; Tetrabenazine | 1975 |
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
Neurobiology and pharmacology of Huntington's disease.
Topics: Brain; Carnosine; Choline O-Acetyltransferase; Cholinergic Fibers; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Huntington Disease; Mental Disorders; Movement; Nerve Degeneration; Norepinephrine; Peptidyl-Dipeptidase A; Physostigmine; Receptors, Muscarinic; Receptors, Neurotransmitter; Serotonin; Tranquilizing Agents | 1977 |
4 trial(s) available for physostigmine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Deanol acetamidobenzoate treatment in choreiform movement disorders.
Topics: Benztropine; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Huntington Disease; Male; Middle Aged; Physostigmine | 1977 |
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia | 1978 |
Dietary enhancement of CNS neurotransmitters.
Topics: Acetylcholine; Administration, Oral; Brain; Choline; Clinical Trials as Topic; Diet; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine; Serotonin; Tryptophan | 1978 |
Studies on choline chloride in neuropsychiatric disease: human and animal data.
Topics: Animals; Choline; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine; Rats | 1978 |
15 other study(ies) available for physostigmine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Cholinergic neuronal defect without cell loss in Huntington's disease.
Topics: Animals; Brain; Brain Chemistry; Case-Control Studies; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Humans; Huntingtin Protein; Huntington Disease; Male; Maze Learning; Membrane Transport Proteins; Memory; Mice; Mice, Transgenic; Motor Endplate; Muscular Atrophy; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Physostigmine; Repressor Proteins; Transcription Factors; Vesicular Acetylcholine Transport Proteins | 2006 |
Dementia in the aged.
Topics: Aged; Cerebral Infarction; Choline; Creutzfeldt-Jakob Syndrome; Dementia; Depressive Disorder; Diagnosis, Differential; Humans; Huntington Disease; Phosphatidylcholines; Physostigmine; Psychoses, Substance-Induced | 1982 |
Effect of cholinergic agents in Huntington's disease: a reappraisal.
Topics: Arecoline; Benztropine; Humans; Huntington Disease; Parasympatholytics; Parasympathomimetics; Physostigmine; Tropanes | 1983 |
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
Topics: Biogenic Amines; Bipolar Disorder; Humans; Huntington Disease; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Psychotic Disorders; Research Design; Schizophrenia; Tranquilizing Agents | 1975 |
[Modern methods of treating Huntington's chorea].
Topics: gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Lithium; Methysergide; Physostigmine; Tetrabenazine | 1976 |
Choline in tardive dyskinesia and Huntington's disease.
Topics: Choline; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Male; Physostigmine | 1976 |
Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
Topics: Choline; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine | 1977 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid | 1977 |
Dimethyl aminoethanol in Huntington's chorea.
Topics: Dihydroxyphenylalanine; Ethanol; Humans; Huntington Disease; Physostigmine | 1973 |
Central cholinergic-anticholinergic antagonism in Huntington's chorea.
Topics: Acetylcholine; Dopamine; Drug Antagonism; Edrophonium; Humans; Huntington Disease; Parasympatholytics; Physostigmine; Scopolamine; Tongue | 1972 |
Physostigmine in rigid Huntington's disease.
Topics: Adult; Female; Genotype; Humans; Huntington Disease; Injections, Intramuscular; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Phenotype; Physostigmine | 1973 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine | 1972 |
Cholinergic and dopaminergic mechanisms in Huntington's chorea.
Topics: Acetylcholine; Adult; Blood Pressure; Dopamine; Female; Heart Rate; Humans; Huntington Disease; Male; Middle Aged; Motor Activity; Movement; Neostigmine; Phenylacetates; Physostigmine; Probenecid; Synaptic Transmission; Tropanes | 1971 |
[Cholinergic and dopaminergic mechanisms in Huntingtons' chorea].
Topics: Acetylcholine; Basal Ganglia; Dopamine; Humans; Huntington Disease; Parkinson Disease; Phenylacetates; Physostigmine; Synaptic Transmission | 1971 |
Physostigmine in choreiform movement disorders.
Topics: Acetylcholine; Adult; Aged; Art; Athetosis; Chorea; Corpus Striatum; Dihydroxyphenylalanine; Female; Handwriting; Humans; Huntington Disease; Injections, Intravenous; Male; Middle Aged; Motor Activity; Motor Skills; Parkinson Disease; Phenothiazines; Physostigmine; Posture; Synaptic Transmission | 1974 |